WANBURYPharmaceuticals
Wanbury Ltd — Cash Flow Statement
₹221.95
+0.00%
Wanbury Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -22.93 Cr | -12.76 Cr | 7.17 Cr | 30.87 Cr | — |
| Issuance Of Debt | 63.82 Cr | 95.00 Cr | 0.00 | — | — |
| Issuance Of Capital Stock | 0.03 Cr | 6.04 Cr | 0.04 Cr | 49.66 Cr | — |
| Capital Expenditure | -49.03 Cr | -17.42 Cr | -12.63 Cr | -9.66 Cr | — |
| End Cash Position | 4.06 Cr | 3.40 Cr | 1.49 Cr | 22.53 Cr | — |
| Beginning Cash Position | 3.40 Cr | 1.49 Cr | 22.53 Cr | 10.00 Cr | — |
| Changes In Cash | 0.66 Cr | 1.91 Cr | -21.03 Cr | 12.52 Cr | — |
| Financing Cash Flow | 25.73 Cr | 13.87 Cr | -31.99 Cr | -28.58 Cr | — |
| Interest Paid Cff | -34.74 Cr | -34.71 Cr | -16.54 Cr | -15.08 Cr | — |
| Net Common Stock Issuance | 0.03 Cr | 6.04 Cr | 0.04 Cr | 49.66 Cr | — |
| Common Stock Issuance | 0.03 Cr | 6.04 Cr | 0.04 Cr | 49.66 Cr | — |
| Net Issuance Payments Of Debt | 63.82 Cr | 45.68 Cr | -12.49 Cr | -60.94 Cr | — |
| Net Long Term Debt Issuance | 63.82 Cr | 45.68 Cr | -12.49 Cr | -60.94 Cr | — |
| Long Term Debt Issuance | 63.82 Cr | 95.00 Cr | 0.00 | — | — |
| Investing Cash Flow | -51.17 Cr | -16.63 Cr | -8.84 Cr | 0.59 Cr | — |
| Interest Received Cfi | 0.63 Cr | 0.22 Cr | 0.27 Cr | 0.56 Cr | — |
| Net Investment Purchase And Sale | -3.18 Cr | -3.00 Cr | 0.33 Cr | -1.11 Cr | — |
| Sale Of Investment | 0.24 Cr | 0.00 | — | — | — |
| Purchase Of Investment | -3.41 Cr | -3.00 Cr | — | — | — |
| Net PPE Purchase And Sale | 0.40 Cr | 3.58 Cr | 0.06 Cr | 10.80 Cr | — |
| Sale Of PPE | 0.40 Cr | 3.58 Cr | 0.06 Cr | 10.80 Cr | — |
| Capital Expenditure Reported | -49.03 Cr | -17.42 Cr | -12.63 Cr | -9.66 Cr | — |
| Operating Cash Flow | 26.10 Cr | 4.66 Cr | 19.80 Cr | 40.52 Cr | — |
| Taxes Refund Paid | -0.37 Cr | -0.18 Cr | -0.17 Cr | -0.16 Cr | — |
| Change In Working Capital | -51.06 Cr | -67.55 Cr | -6.75 Cr | 3.24 Cr | — |
| Change In Other Current Liabilities | -0.44 Cr | -35.05 Cr | -9.12 Cr | 7.22 Cr | — |
| Change In Other Current Assets | -3.26 Cr | -4.57 Cr | 5.16 Cr | -7.03 Cr | — |
| Change In Payable | -22.10 Cr | 5.00 Cr | -26.61 Cr | 56.68 Cr | — |
| Change In Inventory | -1.66 Cr | -14.04 Cr | 27.74 Cr | -24.88 Cr | — |
| Change In Receivables | -25.48 Cr | -19.84 Cr | -5.62 Cr | -28.37 Cr | — |
| Other Non Cash Items | 34.27 Cr | 3.03 Cr | 21.23 Cr | 19.62 Cr | — |
| Stock Based Compensation | 1.14 Cr | -0.53 Cr | 0.86 Cr | 0.71 Cr | — |
| Provisionand Write Offof Assets | -8.63 Cr | 1.08 Cr | -0.08 Cr | -3.58 Cr | — |
| Depreciation And Amortization | 13.31 Cr | 13.03 Cr | 12.38 Cr | 11.45 Cr | — |
| Depreciation | 13.31 Cr | 13.03 Cr | 12.33 Cr | 11.45 Cr | — |
| Gain Loss On Investment Securities | -0.12 Cr | -0.01 Cr | -52000.00 | 40000.00 | — |
| Net Foreign Currency Exchange Gain Loss | -0.24 Cr | -0.29 Cr | 2.56 Cr | -0.02 Cr | — |
| Gain Loss On Sale Of PPE | 0.56 Cr | -0.27 Cr | 0.06 Cr | 0.63 Cr | — |
| Net Income From Continuing Operations | 29.55 Cr | 56.34 Cr | -10.29 Cr | 81.13 Cr | — |
| Repayment Of Debt | — | -49.32 Cr | -12.49 Cr | -60.94 Cr | -10.43 Cr |
| Other Cash Adjustment Outside Changein Cash | — | -1000.00 | 100.00 | 2000.00 | — |
| Long Term Debt Payments | — | -49.32 Cr | -12.49 Cr | -60.94 Cr | -10.43 Cr |
| Net Intangibles Purchase And Sale | — | 0.00 | 3.13 Cr | 0.00 | 0.00 |
| Sale Of Intangibles | — | 0.00 | 3.13 Cr | 0.00 | 0.00 |
| Amortization Cash Flow | — | 0.04 Cr | 0.05 Cr | — | — |
| Net Other Investing Changes | — | — | 0.33 Cr | -1.11 Cr | 12.03 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Wanbury Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.